 |
인쇄하기
취소
|
Late entry of ‘Original’ Sanofi in the Plavix complex market
The original company has made a move. Sanofi, the developing company of ‘Plavix,’ is planning to enter the ‘aspirin’ complex market.
According to the industry concerned on the 11th, Sanofi-Aventis Korea is working on the domestic approval procedure for its products, called ‘Plavix A(clopidogrel+aspirin).’
In Korea, CJ CheilJedang, Jeil Pharmaceutical, Korea United Pharm, Myung In Pharm, SK Ch...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.